Vaccine Research
Indian officials say that a new, inhalable measles vaccine developed at the University of Colorado will have to undergo clinical trials in-country before it can be approved for use in the subcontinent. Dry powder vaccines have huge potential in developing countries, which often have a hard time providing the kind of cold chain supply system needed for traditional shots. Story
The International AIDS Vaccine Initiative and Lentigen today announced a collaboration to design an AIDS vaccine based on Lentigen's technology. Release
VaxInnate presented preliminary Phase II data showing that its VAX125 seasonal flu vaccine was safe and highly immunogenic in the elderly. Report
ImmuneRegen struck a collaboration and research agreement with the Department of Tumor Immunology of the Radboud University Nijmegen Medical Centre to evaluate the uses of Homspera in cancer vaccines. Release
HHS Secretary Kathleen Sebelius noted again last week--this time at the 44th National Immunization Conference in Atlanta--the need for improvement over traditional vaccine making methods. Story
Vaccine Market
Reaping a bumper crop of pandemic vaccine sales, GlaxoSmithKline was able to beat analysts' estimates for the first quarter. GSK booked 698 million pounds from sales of its vaccine, a likely one-time event. Report
If you want to protect the elderly, experts say, vaccinate your kids. Story
India's Shantha Biotech is recalling lots of a 5-in-1 vaccine after the WHO raised safety concerns. Item
The long debate over a link between autism and vaccines just won't die, says Dr. Cynthia Cristofani, a pediatric specialist in Oregon. "Conspiracy theories tend to be popular, and it's hard to undo that kind of damage." Story
And Finally... After 10 years of use, an infant pneumococcal vaccine successfully cut rates of infections among Navajo Indians. Report